Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Clinical Advances in Hematology & Oncology : H&O|May 14, 2021
New approaches to targeting the androgen receptor pathway in prostate cancerPedro Isaacsson Velho, Diogo Assed Bastos, Emmanuel S Antonarakis
Oncology (Williston Park, N.Y.)|July 17, 2020
Oncology Clinical Trials During the COVID-19 PandemicAline Bobato Lara Gongoria, Denis Leonardo Fontes Jardim, Diogo Assed Bastos
Therapeutic Advances in Medical Oncology|July 27, 2011
Combination therapy in high-risk stage II or stage III colon cancer: current practice and future prospectsDiogo Assed Bastos, Suilane Coelho Ribeiro, Daniela de Freitas, et al.
Oncology (Williston Park, N.Y.)|September 23, 2020
Use of Immunotherapy in Patients With Cancer During the COVID-19 PandemicAndrey Soares, Fabio A Schutz, Diogo Assed Bastos, et al.
Autopsy & Case Reports|October 21, 2015
Acquired hemophilia A in a patient with advanced prostate cancerDaniel da Motta Girardi, Douglas Rafael Almeida Silva, Paula Ribeiro Villaça, et al.
Clinical Genitourinary Cancer|October 11, 2025
Impact of Bisphosphonates in Hormone-sensitive Metastatic Prostate Cancer A Systematic Review and Meta-AnalysisGabriel Berlingieri Polho, Adler Araujo Ribeiro Melo, Laerte Canedo Ornelas-Filho, et al.
Journal of Global Oncology|September 23, 2018
Efficacy and Safety of Docetaxel in Elderly Patients With Metastatic Castration-Resistant Prostate CancerManuel Caitano Maia, Allan A Lima Pereira, Liana Valente Lage, et al.
World Journal of Urology|November 2, 2024
Tumor regression after neoadjuvant hormonal therapy in high risk prostate cancer: pathological outcomes from a randomized phase II trialLeonardo Cardili, Diogo Assed Bastos, Eder Nisi Ilario, et al.
Journal of Global Oncology|September 11, 2018
Analysis of Efficacy and Toxicity Profile of First-Line Sunitinib or Pazopanib in Metastatic Clear Cell Renal Cell Carcinoma in the Brazilian PopulationPedro Isaacsson Velho, Mirella Nardo, Manoel Carlos Leonardi de Azevedo Souza, et al.
Pathology Oncology Research : POR|June 26, 2020
Prognostic Value of Systemic Inflammatory Biomarkers in Patients with Metastatic Renal Cell CarcinomaGuilherme Nader Marta, Pedro Isaacsson Velho, Renata R C Bonadio, et al.
Pageof 4